LeonaBio, Inc. Common Stock LONA
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $17.33 (+259.6% upside)
Key Stats
- Today's Range
- $4.18 – $4.90
- 50-Day Range
- $2.21 – $8.90
- 52-Week Range
- $2.21 – $14.21
- Volume
- 333K shs
- Average Volume
- 317K shs
- Market Cap
- $45.41 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.60%
- Days to Cover
- 1.00
About LeonaBio, Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Related Stocks
Compare head-to-head: LONA vs AMGN·LONA vs MRNA·LONA vs TWST·LONA vs HALO
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.